Inceptor Bio
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2450 Perimeter Park Dr 200, Morrisville,...Website
inceptor.bioRevenue
$9.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Inceptor Bio
Founded in 2020, Inceptor Bio is biotechnology company developing multiple next-generation cell and gene therapy platforms to deliver cures for underserved and difficult-to-treat cancers. By partnering with universities, medical centers, and industry leaders, Inceptor Bio advances cell and gene therapy programs from discovery-phase technologies into Phase I and II clinical assets.Explore more
Inceptor Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inceptor Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Inceptor Bio recently announced quarterly report
Funding: Get notified immidiatlly once Inceptor Bio has new funding data
Check if Inceptor Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Inceptor Bio launches new products
Inceptor Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Inceptor Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Inceptor Bio
Click to see if Inceptor Bio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Inceptor Bio
Compare insights from companies similar to Inceptor Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$16.3M
51-200
Private
$224.5M
2018
Ayman KabakibiChief Operating Officer & Executive VP, Research & Development
Company Profile Activity
Activity Insights
Inceptor Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Inceptor Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inceptor Bio.
Inceptor Bio financials insights
Gather financial insights about Inceptor Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$37M
Inceptor Bio Tech Stack
A closer look at the technologies used by Inceptor Bio
Most Recent Scoops
Person-Based
Person-Based
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Move
Board of Directors
Inceptor Bio News & Media
Inceptor Bio Appoints Matthias Schroff, PhD, as Chief Executive Officer
MORRISVILLE, N.C., May 8, 2023 /PRNewswire/ -- Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, announced the appointment of Dr. Matthias Schroff as CEO effective today. Dr. Schroff will also join the Board of Directors. Dr. Schroff succeeds...Inceptor Bio and Avectas Announce Collaboration to Improve Manufacturing of CAR-T Cell Therapies for the Treatment of Solid Tumors
Collaboration brings together Avectas' breakthrough cell engineering technology and Inceptor Bio's CAR-T platform MORRISVILLE, N.C. and DUBLIN, Oct. 12, 2022 /PRNewswire/ -- Inceptor Bio, a cell therapy biotechnology company and Avectas, a cell engineering technology leader, announce...Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation Allogeneic Cell Therapies
MORRISVILLE, N.C., June 30, 2022 /PRNewswire/ -- Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced a collaboration with University of Minnesota. The aim of this collaboration is to build a novel induced pluripotent stem cells...Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers
MORRISVILLE, N.C., May 19, 2022 /PRNewswire/ -- Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the closing of a $37 million Series A financing led by Kineticos Ventures. Proceeds from the Series A financing will be used to...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Inceptor Bio
Sign Up For FreeTo access detailed company insights
Founded in 2020, Inceptor Bio is biotechnology company developing multiple next-generation cell and gene therapy platforms to deliver cures for underserved and difficult-to-treat cancers. By partnering with universities, medical centers, and industry leaders, Inceptor Bio advances cell and gene therapy programs from discovery-phase technologies int... Read More
